abstract |
The present invention relates to toxic mycobacteria, such as Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium tuberculosis, Mycobacterium tuberculosis, Mycobacterium tuberculosis, Targeting fusion proteins, antigen cocktails and immunological compositions, such as vaccines against infections caused by Mycobacterium cannetii, Mycobacterium pinnipedii or Mycobacterium mungi . Fusion proteins, antigen cocktails, and immunological compositions are based on proteins secreted by the ESAT-6 secretion system 1 (ESX-1) and are the most immunodominant M. tuberculosis ( MTB) part of an antigen. [Selection] Figure 6 |